Comparison of three drugs pethidine,butorphanol,dexmedetomidine for treatment of shivering under spinal anaesthesia
Not Applicable
- Conditions
- Health Condition 1: null- ASA I/II/III
- Registration Number
- CTRI/2018/05/013684
- Lead Sponsor
- Bhagat Phool Singh Government Medical College For Women
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Age 18-65 years( any gender)
2.American society of Anaesthesiologists (ASA) grade I , II &III physical status
3.Lower limb surgeries, inguinal, abdominal, urological and gynaecological procedures under spinal anaesthesia, who develop shivering during intra-operative and postoperative period (up to 2 hours) will be included in the study.
Exclusion Criteria
1.Patients with hypothyroidism or hyperthyroidism
2.Morbid Obesity (BMI > 40 kg/m2)
3.Fever (axillary temperature > 37 0 Celsius)
4.History of allergy to drugs.
5.Coagulation disorders
6.Patients with significant neurological, psychiatric, neuromuscular, cardiovascular, pulmonary, renal or hepatic diseases.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome will be to compare the efficacy and response rates of pethidine, butorphanol and dexmedetomidine.Timepoint: The time taken for cessation of shivering will be recorded at 1 minute interval till 5 min and thereafter upto 30 minutes.
- Secondary Outcome Measures
Name Time Method 1.To monitor the vital parameters in all the three groups and compare them subsequently. <br/ ><br>2.To record the incidence of recurrence in all the three groups. <br/ ><br>3.To record and compare the incidence of adverse effects such as nausea, vomiting, sedation, etc. amongst the three groups. <br/ ><br>Timepoint: Maximum Upto Two Hours